Nikkomycin

Nikkomycins are a group of antifungal medications.[1] They work by interfering with the building of the fungal cell wall which results in the fungal cell breaking open.[1] They were discovered in 1976.[1] The specific agent nikkomycin Z has weak activity against Aspergillus fumigatus which may be of benefit when used with other medications,[1] such as caspofungin, ranconazole and amphotericin B, fluconazole or itraconazole.[2]

Structure of nikkomycin Z

Originally identified from Streptomyces tendae, the nikkomycins are chitin synthase inhibitors.[2]

References
  1. Steinbach, WJ; Stevens, DA (1 October 2003). "Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis". Clinical Infectious Diseases. 37 Suppl 3: S157-87. doi:10.1086/376523. PMID 12975751.
  2. Varnava, Kyriakos G.; Ronimus, Ron S.; Sarojini, Vijayalekshmi (November 2017). "A review on comparative mechanistic studies of antimicrobial peptides against archaea". Biotechnology and Bioengineering. 114 (11): 2457–2473. doi:10.1002/bit.26387. PMID 28734066.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.